What’s News, Breaking: Monday, September 11, 2023
FDA APPROVES UPDATED COVID-19
VACCINE FOR EMERGENCY USE
NATIONWIDE — UPDATED COVID-19 VACCINES HAVE BEEN APPROVED AND AUTHORIZED in an action that the U.S. Food and Drug Administration took on Monday, Sept. 11. The updated mRNA COVID-19 vaccines, which have now been approved for emergency use, are formulated to more closely target currently circulating variants and to provide better protection against serious consequences of the virus, and include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5. Individuals 5 years of age and older, regardless of previous vaccination, are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.
Meanwhile, babies and toddlers from age 6 months to four years who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).